Yetzugo is a long-acting HIV-1 capsid inhibitor that reduces the risk of sexually acquired HIV in adults and adolescents.

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

The Michigan Department of Health and Human Services (MDHHS) is encouraging Michigan residents get tested and check their HIV ...

A model that can estimate the need for pre-exposure prophylaxis (PrEP) in the US can help to clarify use patterns to address ...

At the beginning of June, the Texas Department of State Health Services asked all programs funded by the CDC’s HIV Prevention ...

The Supreme Court on Friday granted the HIV-prevention field a historic win — yet with a major caveat — as it upheld a ...

Like other PrEP drugs, if enough of the medication is present when a person is exposed to HIV, it can prevent the virus from ...

The high court found that members of a task force that determines what preventive drugs must be covered can be removed at ...

Chicagoland research labs and community clinics are navigating illegal funding stoppages, censorship, and increasing ...

Models indicate that the worst-case scenario of the Trump administration's HIV-related cuts could result in 3 million deaths.

The Supreme Court upheld free preventive care, rejecting a challenge that threatened coverage for STI testing, cancer ...

The US has approved lenacapavir for HIV prevention. However, experts worry that cuts to the health budget will "squander" the drug's chance of reducing infections.